Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Wells

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Free Radical Biology & Medicine|January 1, 1997
Peroxidase-dependent bioactivation and oxidation of DNA and protein in benzo[a]pyrene-initiated micronucleus formationP M Kim, U DeBoni, P G Wells
Teratology|August 1, 1989
Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleateM Wong, L M Helston, P G Wells
Cancer Research|March 1, 1995
Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblastsD S Vienneau, U DeBoni, P G Wells
Journal of Chromatography|February 27, 1985
Analysis of the toxicologically relevant metabolites of phenytoin in biological samples by high-performance liquid chromatographyJ T Lum, N A Vassanji, P G Wells
Toxicology and Applied Pharmacology|March 1, 1989
Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compoundsP G Wells, M K Nagai, G S Greco
Toxicology and Applied Pharmacology|February 1, 1994
Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo cultureA F Miranda, M J Wiley, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Investigation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone for in vivo and iIn vitro murine embryopathy and embryonic ras mutationsL M Winn, P M Kim, P G Wells
Proceedings of the Royal Society of Medicine|December 9, 2009
Familial XanthomatosisJ N Harris-Jones, G Jones, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 miceT R Ozolins, D L Siksay, P G Wells
Biochemical Pharmacology|November 27, 1995
Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat, and rabbitT R Ozolins, M J Wiley, P G Wells
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Free Radical Biology & Medicine|January 1, 1997
Peroxidase-dependent bioactivation and oxidation of DNA and protein in benzo[a]pyrene-initiated micronucleus formationP M Kim, U DeBoni, P G Wells
Teratology|August 1, 1989
Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleateM Wong, L M Helston, P G Wells
Cancer Research|March 1, 1995
Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblastsD S Vienneau, U DeBoni, P G Wells
Journal of Chromatography|February 27, 1985
Analysis of the toxicologically relevant metabolites of phenytoin in biological samples by high-performance liquid chromatographyJ T Lum, N A Vassanji, P G Wells
Toxicology and Applied Pharmacology|March 1, 1989
Inhibition of trimethadione and dimethadione teratogenicity by the cyclooxygenase inhibitor acetylsalicylic acid: a unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compoundsP G Wells, M K Nagai, G S Greco
Toxicology and Applied Pharmacology|February 1, 1994
Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo cultureA F Miranda, M J Wiley, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Investigation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone for in vivo and iIn vitro murine embryopathy and embryonic ras mutationsL M Winn, P M Kim, P G Wells
Proceedings of the Royal Society of Medicine|December 9, 2009
Familial XanthomatosisJ N Harris-Jones, G Jones, P G Wells
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Modulation of embryonic glutathione peroxidase activity and phenytoin teratogenicity by dietary deprivation of selenium in CD-1 miceT R Ozolins, D L Siksay, P G Wells
Biochemical Pharmacology|November 27, 1995
Phenytoin covalent binding and embryopathy in mouse embryos co-cultured with maternal hepatocytes from mouse, rat, and rabbitT R Ozolins, M J Wiley, P G Wells
Pageof 8